2002 - Relationship between Hepatitis C Virus and Steatosis
MISC (18件)：
Adachi K, Ishihara S, Hashimoto T, Hirakawa K, Ishimura N, Niigaki M, Kaji T, Kawamura A, Sato H, Fujishiro H, Hattori S, Watanabe M, Kinoshita Y / Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansop・・・. Alimentary Pharmacology Therapeutics. 2001. 15, 1187-1191
Adachi K, Ishihara S, Hashimoto T, Hirakawa K, Ishimura N, Niigaki M, Kaji T, Kawamura A, Sato H, Fujishiro H, Hattori S, Watanabe M, Kinoshita Y / Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansop・・・. Alimentary Pharmacology Therapeutics. 2001. 15, 1187-1191
Misa Niigaki, Ryo Fukuda, Sachiko Hamamoto, Norihisa Ishimura, Shunji Ishihara, Shuji Akagi, Makoto Watanabe, Yoshikazu Kinoshita / Role of hepatitis B virus in non-B, non-C chronic liver disease : in vitro proliferation and interferon-β production of・・・. American Journal of Gastroenterology. 2000. 95, 1, 239-247
Misa Niigaki, Ryo Fukuda, Sachiko Hamamoto, Norihisa Ishimura, Shunji Ishihara, Shuji Akagi, Makoto Watanabe, Yoshikazu Kinoshita / Role of hepatitis B virus in non-B, non-C chronic liver disease : in vitro proliferation and interferon-β production of ・・・. American Journal of Gastroenterology. 2000. 95, 1, 239-247
R. Fukuda, N. Ishimura, S. Hamamoto, M. Niigaki, S. Ishihara, S. Akagi, M. Watanabe, Y. Kinoshita / Gene expression of type-I interferon receptors in the liver in chronic hepatitis C is different between patients infected with hepatitis C virus genotyp・・・. Gastroenterology. 1999. 116, 4, A605
